Last edition
News about "Manufacture Exosome-Based Ocular Therapy for APAC"
Pandorum Partners with Nucelion Therapeutics to Manufacture Exosome-Based Ocular Therapy for APAC
Pandorum Technologies, a clinical-stage regenerative medicine company, has entered into a strategic manufacturing collaboration with Nucelion Therapeutics, the contract research, development and manufacturing organisation (CRDMO) arm of Bharat Biotech, to support the production of its exosome-based ocular disease therapy for the Asia-Pacific (APAC).
Manufacture Exosome-Based Ocular Therapy For APAC | 06/01/2026 | By Darshana | 214
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy